Denali Therapeutics Inc. (DNLI)
NASDAQ
19.16
-0.12 (-0.62%)
Closed
Oct 7, 2026
Day's Range
18.8919.43
52 wk Range
13.7527.30
Price Target - DNLI - Denali Therapeutics Inc.
Analyst Price Target
Where analysts expect the price to trade over the next twelve months.
Average‪$ 35.44‬
Current‪$ 19.16‬
Low ‪$ 27.00‬High ‪$ 42.00‬
Low‪$ 27.00‬
Average‪$ 35.44‬
Median‪$ 35.00‬
High‪$ 42.00‬
Implied move to the average target: +85.0%
Recommendations - DNLI - Denali Therapeutics Inc.
Analyst Ratings - DNLI - Denali Therapeutics Inc.
Analyst ratings
Items per row:
Estimates - DNLI - Denali Therapeutics Inc.
Estimate momentum
Current quarter · How the consensus estimate has moved over the last 90 days.
90 days ago-0.53
Now-0.41
Change+23.9%
Revised last month3/1
Growth estimates
Current quarter+45.2%
Next quarter+14.3%
Current year+22.8%
Next year-5.8%
Next 5 years (per year)-2.3%
Past 5 years (per year)+6.3%
EPS estimates
Earnings History - DNLI - Denali Therapeutics Inc.
Estimate surprises
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
